Nuvama Wealth Management Reports Strong Q2 FY27 Results; Board Approves ₹700 Cr Subsidiary Infusion
Nuvama Wealth Management Ltd · Outcome · 06 Nov 2026, 7:33 pm
Nuvama Wealth Management Reports Strong Q2 FY27 Results; Board Approves ₹700 Cr Subsidiary Infusion Nuvama Wealth Management reported a 26% YoY increase in Q2 FY27 consolidated operating PAT to ₹319 Cr (reported PAT up 19% YoY to ₹304 Cr), driven by 21% YoY revenue growth to ₹937 Cr. H1 FY27 operating PAT rose 21% YoY to ₹625 Cr, with RoE at ~29% and client assets expanding 25% YoY to ₹5.5 trillion. On 6th Nov'26, the board also approved equity investments of up to ₹400 Cr in Nuvama Wealth Finance and ₹300 Cr in Nuvama Wealth and Investment.
Original exchange filing (PDF)
More announcements from Nuvama Wealth Management Ltd
- PFA Intimation w.r.t. Allotment of Equity Shares upon exercise of ESOPs/ESARs · 17 Nov 2026
- PFA intimation w.r.t Investor Presentation (US Dollars) · 16 Nov 2026
- Please find attached Earnings Call Transcript · 13 Nov 2026
- PFA Exchange intimation w.r.t. Investor Meet. · 09 Nov 2026
- PFA Exchange intimation w.r.t. Investor Meet. · 09 Nov 2026
- PFA intimation w.r.t Earnings Conference Call · 09 Nov 2026
- PFA intimation w.r.t Investor Presentation · 06 Nov 2026
- PFA intimation w.r.t Acquisition of shares by the Company · 06 Nov 2026
